Document is current
Any future updates will be listed below
-
Authors
Cha, Junha
Kim, Da Hee
Kim, Gamin
Cho, Jae-Won
Sung, Euijeong
Baek, Seungbyn
Hong, Min Hee https://orcid.org/0000-0003-3490-2195
Kim, Chang Gon
Sim, Nam Suk
Hong, Hyun Jun
Lee, Jung Eun
Hemberg, Martin
Park, Seyeon
Yoon, Sun Ock
Ha, Sang-Jun https://orcid.org/0000-0002-1192-6031
Koh, Yoon Woo
Kim, Hye Ryun https://orcid.org/0000-0002-1842-9070
Lee, Insuk https://orcid.org/0000-0003-3146-6180
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03737968 at ClinicalTrials.govDocuments that mention this clinical trial
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes
https://doi.org/10.1136/jitc-2023-008667
Dynamic change of immune phenotype assessed by artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) during neoadjuvant durvalumab with or without tremelimumab (D+/-T) in head and neck squamous cell carcinoma (HNSCC).
https://doi.org/10.1200/jco.2023.41.16_suppl.2578
-
Funding
Funding for this research was provided by:
Korea Drug Development Fund (HN21C1410)
Brain Korea 21 (BK21) FOUR Program (N/A)
Ministry of Science and ICT (2017R1A5A1014560)
Ministry of Science and ICT (2018R1A5A2025079)
Ministry of Science and ICT (2019M3A9B6065192)
Ministry of Science and ICT (2019M3A9B6065221)
Ministry of Science and ICT (2019M3A9B6065231)
Ministry of Science and ICT (2021R1A2C2094629)
Ministry of Science and ICT (HA22C001102)
Yonsei Fellow Program (N/A)
Korean Foundation for Cancer Research (9 CB-2022-C-1)
- License Information
